Bank Of New York Mellon Corp Cara Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$4.89 - $12.27 $1.98 Million - $4.97 Million	405,132 New	405,132 $1.99 Billion
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $3.59 Million - $5.17 Million	404,651 New	404,651 $4.35 Million
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $277,613 - $423,158	33,691 Added 8.47%	431,373 $4.04 Million
Q2 2022 Aug 15, 2022	SELL	$7.45 - $13.84 $309,167 - $574,346	-41,499 Reduced 9.45%	397,682 $3.63 Million
Q1 2022 May 11, 2022	BUY	$9.94 - $12.65 $30,485 - $38,797	3,067 Added 0.7%	439,181 $5.34 Million
Q4 2021 Feb 11, 2022	BUY	$11.99 - $18.14 $264,307 - $399,878	22,044 Added 5.32%	436,114 $5.31 Million
Q3 2021 Nov 12, 2021	BUY	$11.55 - $16.06 $76,183 - $105,931	6,596 Added 1.62%	414,070 $6.4 Million
Q2 2021 Aug 11, 2021	BUY	$12.38 - $29.19 $2.94 Million - $6.94 Million	237,847 Added 140.22%	407,474 $5.81 Million
Q1 2021 May 13, 2021	SELL	$15.07 - $21.71 $129,918 - $187,161	-8,621 Reduced 4.84%	169,627 $3.68 Million
Q4 2020 Feb 09, 2021	SELL	$12.72 - $16.16 $36,582 - $46,476	-2,876 Reduced 1.59%	178,248 $2.7 Million
Q3 2020 Nov 12, 2020	SELL	$12.34 - $17.92 $32,380 - $47,022	-2,624 Reduced 1.43%	181,124 $2.3 Million
Q2 2020 Aug 12, 2020	BUY	$12.39 - $17.33 $61,491 - $86,008	4,963 Added 2.78%	183,748 $3.14 Million
Q1 2020 May 06, 2020	BUY	$9.12 - $17.78 $10,588 - $20,642	1,161 Added 0.65%	178,785 $2.36 Million
Q4 2019 Feb 14, 2020	SELL	$16.11 - $25.98 $328,321 - $529,472	-20,380 Reduced 10.29%	177,624 $2.86 Million
Q3 2019 Nov 07, 2019	BUY	$18.28 - $26.91 $1.03 Million - $1.51 Million	56,163 Added 39.6%	198,004 $3.62 Million
Q2 2019 Aug 12, 2019	SELL	$17.68 - $21.57 $32,973 - $40,228	-1,865 Reduced 1.3%	141,841 $3.05 Million
Q1 2019 May 14, 2019	SELL	$14.41 - $19.64 $28,128 - $38,337	-1,952 Reduced 1.34%	143,706 $2.82 Million
Q4 2018 Feb 11, 2019	BUY	$12.45 - $23.47 $42,504 - $80,126	3,414 Added 2.4%	145,658 $1.89 Million
Q3 2018 Nov 09, 2018	BUY	$17.57 - $23.95 $241,974 - $329,839	13,772 Added 10.72%	142,244 $0
Q2 2018 Aug 06, 2018	SELL	$11.6 - $19.27 $614 - $1,021	-53 Reduced 0.04%	128,472 $2.46 Million
Q1 2018 May 15, 2018	BUY	$11.77 - $16.08 $47,350 - $64,689	4,023 Added 3.23%	128,525 $1.59 Million
Q4 2017 Feb 09, 2018	BUY	$11.86 - $14.08 $1.48 Million - $1.75 Million	124,502	124,502 $1.52 Million

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$11 Million
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$8.31 Million
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$7.59 Million
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$5.43 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$5.41 Million
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account